FERMT3

FERM domain containing kindlin 3, the group of Fermitins|Pleckstrin homology domain containing|FERM domain containing

Basic information

Region (hg38): 11:64205926-64223896

Links

ENSG00000149781NCBI:83706OMIM:607901HGNC:23151Uniprot:Q86UX7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • leukocyte adhesion deficiency 3 (Strong), mode of inheritance: AR
  • leukocyte adhesion deficiency 3 (Strong), mode of inheritance: AR
  • leukocyte adhesion deficiency 3 (Supportive), mode of inheritance: AR
  • leukocyte adhesion deficiency 3 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Leukocyte adhesion deficiency, type IIIARAllergy/Immunology/Infectious; HematologicAntiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial; Individuals may have hematologic anomalies, and treatment (which may include RBC and platelet transfusions) may be indicated; BMT has been describedAllergy/Immunology/Infectious; Hematologic9312170; 12595312; 17185466; 19234460; 19064721; 20357244; 21441448

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FERMT3 gene.

  • Leukocyte adhesion deficiency 3 (6 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FERMT3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
134
clinvar
7
clinvar
145
missense
185
clinvar
5
clinvar
3
clinvar
193
nonsense
1
clinvar
2
clinvar
3
start loss
1
clinvar
1
frameshift
5
clinvar
2
clinvar
7
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
1
clinvar
4
clinvar
5
splice region
9
21
5
35
non coding
2
clinvar
66
clinvar
17
clinvar
85
Total 6 5 199 205 27

Variants in FERMT3

This is a list of pathogenic ClinVar variants found in the FERMT3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-64207366-T-G Leukocyte adhesion deficiency 3 Uncertain significance (Mar 12, 2022)1912006
11-64207369-C-T Leukocyte adhesion deficiency 3 Uncertain significance (Oct 03, 2019)940984
11-64207370-G-A Leukocyte adhesion deficiency 3 Likely benign (Apr 18, 2023)1111579
11-64207373-G-A Leukocyte adhesion deficiency 3 Likely benign (May 23, 2023)2915197
11-64207382-A-G Leukocyte adhesion deficiency 3 Likely benign (Feb 14, 2023)2900561
11-64207388-C-T Leukocyte adhesion deficiency 3 Likely benign (Jul 06, 2022)1606229
11-64207389-G-A Leukocyte adhesion deficiency 3 Uncertain significance (Dec 18, 2019)844514
11-64207391-G-A FERMT3-related disorder Likely benign (May 23, 2019)3039540
11-64207391-G-T Leukocyte adhesion deficiency 3 Likely benign (Sep 07, 2022)1501334
11-64207392-G-A Leukocyte adhesion deficiency 3 Uncertain significance (Sep 01, 2021)1477670
11-64207398-A-G Leukocyte adhesion deficiency 3 Uncertain significance (Sep 27, 2022)950195
11-64207400-C-T Leukocyte adhesion deficiency 3 Likely benign (Dec 16, 2023)2897360
11-64207401-G-A Leukocyte adhesion deficiency 3 • Inborn genetic diseases Uncertain significance (Nov 29, 2021)1483571
11-64207405-C-G Leukocyte adhesion deficiency 3 Uncertain significance (Aug 23, 2022)643214
11-64207406-G-A Leukocyte adhesion deficiency 3 Likely benign (Oct 05, 2022)1121807
11-64207409-A-G Leukocyte adhesion deficiency 3 Likely benign (Apr 30, 2023)2162556
11-64207410-T-C Leukocyte adhesion deficiency 3 Uncertain significance (Mar 01, 2022)2105532
11-64207412-G-A Leukocyte adhesion deficiency 3 Pathogenic (Mar 01, 2009)2709
11-64207416-C-G Leukocyte adhesion deficiency 3 • Inborn genetic diseases Uncertain significance (Jul 31, 2023)1376469
11-64207420-G-A Leukocyte adhesion deficiency 3 • Inborn genetic diseases Uncertain significance (Oct 17, 2022)580905
11-64207420-G-T Leukocyte adhesion deficiency 3 Uncertain significance (Jul 26, 2020)1051610
11-64207438-A-G Leukocyte adhesion deficiency 3 Uncertain significance (Mar 03, 2022)1400293
11-64207439-G-A Leukocyte adhesion deficiency 3 Likely benign (Oct 14, 2023)1084480
11-64207450-C-T Leukocyte adhesion deficiency 3 Uncertain significance (Dec 11, 2023)417964
11-64207451-C-T Leukocyte adhesion deficiency 3 Likely benign (Jun 16, 2023)3000938

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FERMT3protein_codingprotein_codingENST00000279227 1417205
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0002601.001256960521257480.000207
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.513324190.7930.00003024296
Missense in Polyphen79125.170.631151369
Synonymous-0.2621881831.020.00001301333
Loss of Function3.641336.80.3530.00000207370

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002350.000235
Ashkenazi Jewish0.00009970.0000992
East Asian0.0001090.000109
Finnish0.00004850.0000462
European (Non-Finnish)0.0002950.000290
Middle Eastern0.0001090.000109
South Asian0.0002290.000229
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a central role in cell adhesion in hematopoietic cells (PubMed:19234463, PubMed:26359933). Acts by activating the integrin beta-1-3 (ITGB1, ITGB2 and ITGB3) (By similarity). Required for integrin-mediated platelet adhesion and leukocyte adhesion to endothelial cells (PubMed:19234460). Required for activation of integrin beta-2 (ITGB2) in polymorphonuclear granulocytes (PMNs) (By similarity). {ECO:0000250|UniProtKB:Q8K1B8, ECO:0000269|PubMed:19234460, ECO:0000269|PubMed:19234463, ECO:0000269|PubMed:26359933}.;
Disease
DISEASE: Leukocyte adhesion deficiency 3 (LAD3) [MIM:612840]: A disorder characterized by recurrent bacterial infections without pus formation, leukocytosis and major bleeding disorders. {ECO:0000269|PubMed:18779414, ECO:0000269|PubMed:19064721, ECO:0000269|PubMed:19234460, ECO:0000269|PubMed:19234463, ECO:0000269|PubMed:19617577, ECO:0000269|PubMed:26359933}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Platelet activation - Homo sapiens (human);Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis (Consensus)

Recessive Scores

pRec
0.126

Intolerance Scores

loftool
0.305
rvis_EVS
-0.19
rvis_percentile_EVS
39.24

Haploinsufficiency Scores

pHI
0.171
hipred
Y
hipred_score
0.652
ghis
0.551

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.813

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fermt3
Phenotype
digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
fermt3b
Affected structure
intersegmental vessel
Phenotype tag
abnormal
Phenotype quality
non-functional

Gene ontology

Biological process
platelet degranulation;leukocyte cell-cell adhesion;integrin-mediated signaling pathway;positive regulation of cell migration;integrin activation;regulation of cell-cell adhesion mediated by integrin;substrate adhesion-dependent cell spreading;platelet aggregation
Cellular component
podosome;extracellular region;membrane;cell junction;platelet alpha granule lumen;cell projection;extracellular exosome
Molecular function
integrin binding